News & Stories

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology analysis system that can accurately recognize multiple types of cancer using only a minimal number of samples—without requiring any additional training. This breakthrough significantly enhances the flexibility and efficiency of AI-assisted medical care, marking a major step forward toward the widespread adoption of intelligent pathology.

What do the eggs of sea urchins, car exhaust, sticky tape, and risk and reward have in common? Each sparked a discovery that secured a Nobel Prize.Four Nobel laureates shared fascinating stories from their decades of research experience at a fireside chat with over 400 students, faculty, and members of the public. The event, Nobel Heroes@HKUST, was part of HKUST’s 35th anniversary celebrations. The laureates were:Prof. Tim HUNT (2001 Nobel Prize in Physiology or Medicine)Prof. Louis J. IGNARRO (1998 Nobel Prize in Physiology or Medicine)Prof. Robert C. MERTON (1997 Nobel Memorial Prize in Economic Sciences)Prof. Konstantin NOVOSELOV (2010 Nobel Prize in Physics)

With the rapid aging of Hong Kong's population, it is projected that by 2039, individuals aged 65 or above will account for over 30% of the total population, making early intervention for cognitive health an urgent necessity. This demographic shift highlights the critical need for effective strategies to address cognitive decline in the elderly.One of these strategies is to promote the detection of Alzheimer's disease at the community level. But this approach faces numerous obstacles. High testing costs, invasive procedures, and a lack of public awareness about the importance of early detection have hindered accessibility. Caring for our communityRecognizing these challenges, the NeuroCare Community Project was launched to bridge this gap. This project supports early and proactive intervention at the community level to delay the symptoms of Alzheimer’s disease, thus alleviating pressure on caregivers and society at large.

The Hong Kong University of Science and Technology (HKUST) today launched the NeuroCare Community Project (the Project), a five-year initiative to enhance early detection of Alzheimer’s risk for Hong Kong’s elderly who need support. Working with over 40 community centers under more than a dozen non-governmental organizations (NGOs), and in collaboration with Tung Wah College (TWC), the Project aims to screen 6,000 community-dwelling elderly aged 60-75, shifting the focus from late-stage diagnosis to proactive, community-based care.With the rapid aging of Hong Kong’s population, it is projected that by 2039, individuals aged 65 or above will account for over 30% of the total population, making early intervention for cognitive health an urgent necessity. 

A research team led by Prof. GUO Yusong, Associate Professor of the Division of Life Science at The Hong Kong University of Science and Technology (HKUST) has made a significant breakthrough in understanding how cells manage the intricate internal transport of proteins, a process fundamental to life and implicated in several hereditary diseases. By employing an innovative vesicle proteomics platform, the team has systematically identified new cargo proteins and key accessory factors for two critical cellular transport complexes, AP-1 and AP-4. The findings, published in Proceedings of the National Academy of Sciences (PNAS), combine innovative vesicle reconstitution techniques with quantitative mass spectrometry-based proteomics to unveil a comprehensive map of previously unknown cargo proteins and regulatory factors.

With the support of the HKSAR Government, The Hong Kong University of Science and Technology (HKUST) has commenced preparations to establish a new medical school. Dedicated to training a new generation of tech-savvy doctors, the School will bolster the future readiness of the local healthcare system and advance Hong Kong's development as an international hub for medical training, research, and innovation.

The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence (AI) system designed to transform the entire pathology workflow for cancer care. The system was developed by an HKUST research team led by Prof. CHEN Hao, Director of Collaboration Center for Medical and Engineering Innovation, and Assistant Professor of the Department of Computer Science and Engineering and Department of Chemical and Biological Engineering. SmartPath provides integrated support for clinical diagnosis, subtyping, biomarker quantification, treatment response assessment, and prognostic follow-up across a wide spectrum of cancers, aiming to accelerate turnaround times and enhance the personalization of treatment plans.

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 H157Y, significantly increases the risk of Alzheimer’s disease (AD) in individuals of ethnic Chinese descent. The research reveals that this variant confers a risk level comparable to that of the strongest known genetic risk factor for AD, APOE-ε4, and is associated with more rapid clinical progression and more severe neurodegeneration.This is the first in the field to conduct an in-depth family-based clinical case study on a Chinese-enriched genetic risk factor for AD, the TREM2 H157Y variant. The findings, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, have profound implications for disease monitoring and patient management.